Recent Advances and Impact of Chemotherapeutic and Antiangiogenic Nanoformulations for Combination Cancer Therapy
Rajora, A.K.; Ravishankar, D.; Zhang, H.; Rosenholm, J.M. Recent Advances and Impact of Chemotherapeutic and Antiangiogenic Nanoformulations for Combination Cancer Therapy. Pharmaceutics 2020, 12, 592. https://doi.org/10.3390/pharmaceutics12060592
Rajora AK, Ravishankar D, Zhang H, Rosenholm JM. Recent Advances and Impact of Chemotherapeutic and Antiangiogenic Nanoformulations for Combination Cancer Therapy. Pharmaceutics. 2020; 12(6):592. https://doi.org/10.3390/pharmaceutics12060592
Chicago/Turabian StyleRajora, Amit K., Divyashree Ravishankar, Hongbo Zhang, and Jessica M. Rosenholm. 2020. "Recent Advances and Impact of Chemotherapeutic and Antiangiogenic Nanoformulations for Combination Cancer Therapy" Pharmaceutics 12, no. 6: 592. https://doi.org/10.3390/pharmaceutics12060592